HHS launches $500M universal vaccine platform as RFK Jr. shakes up US vaccine policynews2025-05-01T20:01:49+00:00May 1st, 2025|Endpoints News|
Vaxart says stop-work order was lifted on next-gen Covid vaccine news2025-04-28T18:43:51+00:00April 28th, 2025|Endpoints News|
Novavax responds to FDA’s request for new Covid vaccine trialnews2025-04-28T17:48:21+00:00April 28th, 2025|Endpoints News|
FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approvalnews2025-04-23T12:06:09+00:00April 23rd, 2025|Endpoints News|
Vaccine biotechs get stop-work orders for their next-gen Covid worknews2025-04-22T19:07:46+00:00April 22nd, 2025|Endpoints News|
Moderna stands by its Covid vaccine patents after PTAB decisionnews2025-03-06T19:52:02+00:00March 6th, 2025|Endpoints News|
Shionogi lands $375M from HHS to develop preventive drug for Covid-19news2025-01-16T20:05:21+00:00January 16th, 2025|Endpoints News|
Moderna lowers 2025 revenue estimate, announces more cost cutsnews2025-01-13T19:43:33+00:00January 13th, 2025|Endpoints News|
Leyden Labs gets $70M to test if nasal sprays can help protect against virusesnews2025-01-09T13:00:32+00:00January 9th, 2025|Endpoints News|
BioNTech settles with NIH, UPenn in Covid vaccine disputes and will pay royaltiesnews2024-12-27T15:23:42+00:00December 27th, 2024|Endpoints News|
